The Organising Committee comprises:
- Professor Philip Steer, Emeritus Professor of Obstetrics at Imperial College, Editor Emeritus of BJOG
- Dr Guduru Gopal Rao, OBE, Consultant Microbiologist, London North West Healthcare NHS Trust
- Dr Alison Bedford Russell, Clinical Director, Birmingham Women’s Neonatal Intensive Care Unit
- Mrs Philippa Cox, Consultant Midwife/Supervisor of Midwives, Homerton University Hospital NHS Foundation Trust
The one-day conference is supported by:
Group B Strep Support
Group B Strep Support is proud to support the one day conference.
Since 1996, GBSS has had one overarching objective – to reduce preventable cases of Group B Strep (GBS) infection in babies to save infant lives and prevent disability.
Supported by an eminent Medical Advisory Panel, the charity provides up-to-date and accurate information about GBS to midwives, doctors and families. GBSS is the primary provider of GBS
patient information to UK maternity units, and supports concerned and affected families.
GBSS campaigns for improvements to national guidance, contributing to relevant UK guidelines developed by public health bodies such as PHE, NICE, RCOG and UKNSC. The charity also campaigns to improve awareness of GBS, and for the introduction of safe, effective and GBS-specific testing.
The UK’s risk-based prevention strategy, introduced in 2003, has failed to reduce the rate of GBS infections in newborn babies, and the numbers have been rising. GBS remains the UK’s most common
cause of severe bacterial infection in newborn babies and of meningitis in babies under three months.
Group B Strep Support remains committed to promoting the offer of routine GBS-specific screening which has proved effective in so many other countries.
Meningitis Research Foundation
Meningitis Research Foundation supports the one day conference on Prevention of Group B Strep infection in neonates: the way forward on the UK.
Following the recent announcements about the introduction of MenB and MenACWY vaccines which will offer enhanced protection against meningitis and septicaemia for babies and adolescents, neonatal meningitis is now the leading cause for concern in Meningitis Research Foundation’s fight against the disease, and Group B Streptococcal infection causes the overwhelming number of cases.
Research into Group B Strep meningitis is a principal theme for future support by Meningitis Research Foundation. One new study being undertaken will look at cost-effectiveness models for any future vaccines, based on the recent experience with the MenB vaccine.
Meningitis Research Foundation has also just completed a national survey of treatment and clinical protocols for neonatal meningitis, which will be published shortly. The overall message is that there needs to be greater consistency in clinical practice, with wide variations being revealed.